Regarding IL23R, the statistical power of our study to detect the described odds ratios in previous GWASs on different autoimmune diseases [16,34,35] was higher than 80%, considering the strong effect sizes observed in those studies for the analyzed IL23R variants (Table 3). This evidence concerns the gene IL23R and autoimmune disease.